Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

By sjmartinez • November 7, 2024

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03826-6. Epub ahead of print. PMID: 39505759.

Tags: General Internal Medicine, health-related quality of life, patient-reported outcomes, PROMIS-16, PROMIS-29 + 2, Publications, Short form validation

A Need for Front-of-Package Labeling in an Unhealthy Food Environment-Let’s Label It

DeCan CL, Thure KA. A Need for Front-of-Package Labeling in an Unhealthy Food Environment-Let's Label It. JAMA Intern Med. 2025 May 12. doi: 10.1001/jamainternmed.2025.1404. Epub[...]

Rizatriptan vs Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial

Staab JP, Eggers SDZ, Jen JC, LeMahieu AM, Geske JR, Liu H, Hofschulte DR, Gonzalez GR, Neff BA, Shepard NT, McCaslin DL, Baloh RW. Rizatriptan[...]

Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get[...]